We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
Building upon a successful end-of-Phase 2 meeting, received FDA βStudy May Proceedβ letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced...
BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
BRISBANE, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (βTempestβ or the βCompanyβ), a clinical-stage biotechnology company developing first-in-classi...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0364 | -3.92918825561 | 0.9264 | 0.9392 | 0.8 | 2043626 | 0.8732244 | CS |
4 | -0.17 | -16.0377358491 | 1.06 | 1.21 | 0.8 | 2846884 | 1.00274856 | CS |
12 | -0.47 | -34.5588235294 | 1.36 | 1.59 | 0.8 | 3343758 | 1.08695062 | CS |
26 | -2.47 | -73.5119047619 | 3.36 | 3.6499 | 0.8 | 3000656 | 1.37835776 | CS |
52 | -3.01 | -77.1794871795 | 3.9 | 6 | 0.8 | 1998135 | 2.03395552 | CS |
156 | -9.68 | -91.5799432356 | 10.57 | 10.57 | 0.17 | 1612286 | 4.33980825 | CS |
260 | -12.92 | -93.5553946416 | 13.81 | 41 | 0.17 | 1468188 | 4.85816231 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions